From Nvidia: 2024-08-07 09:00:20

Techbio, combining data, technology, and biology, is transforming the biopharmaceutical industry with the help of AI. Recursion CEO Chris Gibson discusses how AI and machine learning speed up drug discovery, lower costs, and increase efficiency. The future holds using natural language prompts to interact with AI systems in the biopharmaceutical field.

Caristo Diagnostics utilizes AI in cardiac CT scans for detecting coronary inflammation, improving treatment plans, and predicting risks for patients. AI-powered solutions in healthcare, like annalise.ai from Harrison.ai, streamline radiology image analysis and reduce misdiagnoses. Matice Biosciences uses AI to study regenerative animal species for medical breakthroughs, aiming to develop scarless injury treatments. NVIDIA experts discuss the fusion of AI, crowdsourcing, and machine learning to enhance vaccine distribution and drug discovery worldwide.



Read more at Nvidia: Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI